A bioluminescent indicator glows when a cancer drug is active inside the brain, identifying which medications cross the blood-brain barrier.
Category: Drug Development
Basic biochemistry research leads to heart-saving drug
Researchers at Stanford Medicine discovered the mechanism for a heart condition and developed a drug to treat it.
Machine learning could enable faster, less costly epilepsy drugs
Researchers created an algorithm to determine if mice have epilepsy and whether they have been treated with seizure drugs.
Cancer-detecting wearable may offer better way to monitor tumors
Researchers from Stanford have developed a wearable sensor to monitor the size of tumors, which could assist new cancer drug evaluations.
Molecular movie maker
Researchers are harnessing an imaging technique called cryogenic electron microscopy to design drugs and better understand disease.
Stanford Medicine magazine explores the molecules within us
Stanford Medicine magazine explores the molecules behind human biology and how understanding them fuels medical discoveries and innovations.
Preparing for the viruses we’ve yet to meet
Researchers at Stanford Medicine are working to develop antivirals to stop the current pandemic and prevent ones.
Precision medicine predicts best ulcerative colitis care for teens
Stanford researchers are developing a faster way to match each ulcerative colitis patient with the treatment that will work best for them.
Bringing principles of ethics to AI and drug design
Researchers discuss the need for ethics and its integration into research projects that harness artificial intelligence.
New drug gives patient his sight back
A Stanford patient improved greatly after being the first person with sight-threatening thyroid eye disease to receive the drug teprotumumab.
Engineered tissue sent into space to test muscle loss drugs
To help us understand muscle loss as we age, a Stanford Medicine research team’s engineered tissue is sent to the International Space Station.
Keeping treatment-resistant skin cancer cells in check
Anthony Oro is devoted to understanding the origin of basal cell carcinomas. Now he's found how some become resistant to a common treatment.
Computer simulation may yield new COVID-19 drug
Stanford Medicine researchers have discovered a drug that could potentially be used to stave off SARS-CoV-2, the virus that causes COVID-19.
Stanford’s new Innovative Medicines Accelerator is already contributing to COVID-19 effort — and much more is planned
The Innovative Medicines Accelerator builds on existing programs at Stanford — but fills in gaps to help researchers turn ideas into drugs.
Lyme disease bacteria eradicated by new drug in early tests
A study provides evidence that the drug azlocillin eliminates the bacteria that cause Lyme disease at the onset of infection in lab mice and cultures.
On the importance of culture, partnerships and diversity at the Dean’s Lecture Series
At a recent Dean's Lecture Series, Dean Lloyd Minor discussed organizational culture and diversity with Emma Walmsley, CEO of GlaxoSmithKline.